Below are the financial statements of Xenon Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 142.71a | 148.64a |
| Marketable securities | 484.19a | 489.44a |
| Accounts receivable | 1.47a | 0.87a |
| Prepaid expenses and other current assets | 6.89a | 6.01a |
| Marketable securities, long-term | 127.5a | 292.79a |
| Operating lease right-of-use asset, net | 7.94a | 9.19a |
| Property, plant and equipment, net | 10.28a | 9.65a |
| Deferred tax assets | 9.67a | 0.8a |
| Prepaid expenses, long-term | 7.5a | 7.4a |
| Total assets | 798.14a | 964.8a |
| Liabilities and shareholders' equity | — | — |
| Current liabilities | — | — |
| Accounts payable and accrued liabilities | 34.22a | 25.97a |
| Operating lease liability | 1.37a | 1.3a |
| Operating lease liability, long-term | 7.65a | 9.6a |
| Total liabilities | 43.24a | 36.88a |
| Shareholders' equity | — | — |
| Common shares | 1,456.84a | 1,436.37a |
| Additional paid-in capital | 199.15a | 156.76a |
| Accumulated deficit | -899.47a | -665.14a |
| Accumulated other comprehensive loss | -1.61a | -0.08a |
| Total shareholders' equity | 754.9a | 927.92a |
| Total liabilities and shareholders' equity | 798.14a | 964.8a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.